1-3 of 3
Elinborg Ostermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Fc-Engineered Antibody to CD33 with Enhanced ADCC Activity for Treatment of AML

Karl-Heinz Heider, PhD, Renate Konopitzky, PhD, Elinborg Ostermann, PhD, Herbert Lamche, PhD, Zaruhi Kuepcue, PhD, Christian Koessl, Ph.D., Paul Adam, Ph.D., Eric Borges, PhD
Journal: Blood
Blood (2012) 120 (21): 1363.
https://doi.org/10.1182/blood.V120.21.1363.1363
Published: 2012
Journal Articles

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

Karl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, Matthias Volden, Stephan Stilgenbauer, Elinborg Ostermann, Anke Baum, Herbert Lamche, Zaruhi Küpcü, Alexander Jacobi, Steffen Müller, Ulrich Hirt, Günther R. Adolf, Eric Borges
Journal: Blood
Blood (2011) 118 (15): 4159–4168.
https://doi.org/10.1182/blood-2011-04-351932
Published: 2011
Includes: Supplemental data
Journal Articles

Novel Fc-Engineered Antibodies to CD37 with Pro-Apoptotic and Enhanced ADCC Activity

Karl-Heinz Heider, PhD, Elinborg Ostermann, PhD, Herbert Lamche, PhD, Zaruhi Kuepcue, PhD, Alexander Jacobi, PhD, Renate Konopitzky, PhD, Ulrich Hirt, PhD, Volker Reichardt, MD, Eric Borges, PhD
Journal: Blood
Blood (2010) 116 (21): 3916.
https://doi.org/10.1182/blood.V116.21.3916.3916
Published: 2010